BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 19050364)

  • 1. Macrolide resistance determinants in erythromycin-resistant Streptococcus pneumoniae in Turkey.
    Gulay Z; Ozbek OA; Bicmen M; Gur D
    Jpn J Infect Dis; 2008 Nov; 61(6):490-3. PubMed ID: 19050364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROTEKT US 2001-2002.
    Farrell DJ; Jenkins SG
    J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i17-22. PubMed ID: 15265832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP).
    Song JH; Chang HH; Suh JY; Ko KS; Jung SI; Oh WS; Peck KR; Lee NY; Yang Y; Chongthaleong A; Aswapokee N; Chiu CH; Lalitha MK; Perera J; Yee TT; Kumararasinghe G; Jamal F; Kamarulazaman A; Parasakthi N; Van PH; So T; Ng TK;
    J Antimicrob Chemother; 2004 Mar; 53(3):457-63. PubMed ID: 14963068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterisation of Hungarian macrolide-resistant Streptococcus pneumoniae isolates, including three highly resistant strains with the mef gene.
    Dobay O; Rozgonyi F; Amyes SG
    Int J Antimicrob Agents; 2005 Jun; 25(6):488-95. PubMed ID: 15878263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic and genotypic characterization of macrolide resistant Streptococcus pneumoniae recovered from adult patients with community-acquired pneumonia in an Argentinian teaching hospital.
    Bonofiglio L; Ojeda MI; de Mier C; Vay C; Famiglietti A; Gutkind G; Mollerach M
    Int J Antimicrob Agents; 2005 Mar; 25(3):260-3. PubMed ID: 15737523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of erythromycin-resistant Streptococcus pneumoniae from Asian countries that contains erm(B) and mef(A) genes.
    Ko KS; Song JH
    J Infect Dis; 2004 Aug; 190(4):739-47. PubMed ID: 15272402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mef(A), mef(E) and a new mef allele in macrolide-resistant Streptococcus spp. isolates from Norway.
    Sangvik M; Littauer P; Simonsen GS; Sundsfjord A; Dahl KH
    J Antimicrob Chemother; 2005 Nov; 56(5):841-6. PubMed ID: 16172106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of macrolide resistance in clinical pneumococcal isolates in France.
    Fitoussi F; Doit C; Geslin P; Brahimi N; Bingen E
    Antimicrob Agents Chemother; 2001 Feb; 45(2):636-8. PubMed ID: 11158772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and molecular analysis of macrolide and fluoroquinolone resistance among isolates of Streptococcus pneumoniae collected during the 2000-2001 PROTEKT US Study.
    Brown SD; Farrell DJ; Morrissey I
    J Clin Microbiol; 2004 Nov; 42(11):4980-7. PubMed ID: 15528684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of macrolide resistance in clinical pneumococcal isolates in a university hospital, Ankara, Turkey.
    Sener B; Köseoglu O; Gür D; Bryskier A
    J Chemother; 2005 Feb; 17(1):31-5. PubMed ID: 15828441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic susceptibility according to genotype of penicillin-binding protein and macrolide resistance genes, and serotype of Streptococcus pneumoniae isolates from community-acquired pneumonia in children.
    Chiba N; Kobayashi R; Hasegawa K; Morozumi M; Nakayama E; Tajima T; Iwata S; Ubukata K;
    J Antimicrob Chemother; 2005 Oct; 56(4):756-60. PubMed ID: 16131518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal dissemination of macrolide-resistant and penicillin-susceptible serotype 3 and penicillin-resistant Taiwan 19F-14 and 23F-15 Streptococcus pneumoniae isolates in Japan: a pilot surveillance study.
    Kasahara K; Maeda K; Mikasa K; Uno K; Takahashi K; Konishi M; Yoshimoto E; Murakawa K; Kita E; Kimura H
    J Clin Microbiol; 2005 Apr; 43(4):1640-5. PubMed ID: 15814978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro susceptibility and molecular characterisation of macrolide resistance mechanisms among Streptococcus pneumonia isolates in The Netherlands: the DUEL 2 study.
    Neeleman C; De Valk JA; Klaassen CH; Meijers S; Mouton JW
    Clin Microbiol Infect; 2005 Apr; 11(4):312-8. PubMed ID: 15760429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterisation of macrolide resistance mechanisms of Streptococcus pneumoniae and Streptococcus pyogenes isolated in Germany, 2002-2003.
    Reinert RR; Franken C; van der Linden M; Lütticken R; Cil M; Al-Lahham A
    Int J Antimicrob Agents; 2004 Jul; 24(1):43-7. PubMed ID: 15225860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiology of penicillin-resistant Streptococcus pneumoniae in a university hospital, Ankara, Turkey.
    Pinar A; Köseoğlu O; Yenişehirli G; Sener B
    Clin Microbiol Infect; 2004 Aug; 10(8):718-23. PubMed ID: 15301674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of the ermB gene among erythromycin-resistant streptococcus pneumoniae isolates in Germany during the winter of 2000-2001 and in vitro activity of telithromycin.
    Kresken M; Henrichfreise B; Bagel S; Brauers J; Wiedemann B
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3193-5. PubMed ID: 15273149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrolide-resistance mechanisms in Streptococcus pneumoniae isolates from Belgium.
    Van Eldere J; Meekers E; Lagrou K; Massonet C; Canu A; Devenyns I; Verhaegen J; Syrogiannopoulos G; Leclercq R
    Clin Microbiol Infect; 2005 Apr; 11(4):332-4. PubMed ID: 15760433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of macrolide resistance genes erm(B) and mef(A) among 160 penicillin-intermediate clinical isolates of Streptococcus pneumoniae isolated in southern France.
    Marchandin H; Jean-Pierre H; Jumas-Bilak E; Isson L; Drouillard B; Darbas H; Carrière C
    Pathol Biol (Paris); 2001 Sep; 49(7):522-7. PubMed ID: 11642013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular epidemiology and prevalence of macrolide efflux genes mef(A) and mef(E) in Streptococcus pneumoniae obtained in Canada from 1997 to 2002.
    Wierzbowski AK; Swedlo D; Boyd D; Mulvey M; Nichol KA; Hoban DJ; Zhanel GG
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1257-61. PubMed ID: 15728944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of erm(A) and mef(B) erythromycin resistance determinants in isolates of Streptococcus pneumoniae from New Zealand.
    Bean DC; Klena JD
    J Antimicrob Chemother; 2002 Oct; 50(4):597-9. PubMed ID: 12356808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.